Alembic Pharma Shares Rally 4% on Securing Final USFDA Approval
Shares of Alembic Pharmaceuticals Ltd rallied 4% on Monday, 17 November, after the company announced securing final approval from the USFDA for its angina medication....
Tag : Alembic Pharmaceuticals Ltd
Alembic Pharma Shares Slump Despite USFDA Approval
Shares of Alembic Pharmaceuticals Ltd were trading in the red and 1% lower on 29 October despite the company announcing securing final approval from the...
Alembic Pharma Shares Trade 2% Higher on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd increased 2% on Tuesday, 19 August 2025, on securing a final approval from the USFDA. Alembic Pharmaceuticals gained final approval...
Alembic Pharma Shares Up 2% on USFDA Approval
Shares of Alembic Pharmaceuticals Ltd rose more than 2% on Monday, 18 August, after the company announced that it had achieved final USFDA approval. In...
Alembic Pharma Shares Surge 2% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd surged more than 2% on 28 July after the company announced securing final approval from the USFDA for Carbamazepine Extended-Release...
Alembic Pharma Shares Surge 2% on Acquiring Utility Therapeutics
Shares of Alembic Pharmaceuticals Ltd surged 2% on 3 July after the company’s wholly-owned subsidiary, Alembic Pharmaceuticals Inc., purchased Utility Therapeutics Ltd. to broaden its...
Alembic Pharma Shares Skyrocketed 14% on USFDA Final Approval
Shares of Alembic Pharmaceuticals Ltd skyrocketed more than 14% on 30 June after the company announced on Sunday that it had received final USFDA approval...
Alembic Pharma Secures EIR from USFDA
Alembic Pharmaceuticals Ltd announced on Wednesday, 18 June, that it received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for...
Alembic Pharma Shares Slump 2% on 4 Observations
Shares of Alembic Pharmaceuticals Ltd plummeted roughly 2% in early trading on 2 June after the company got four observations from the United States Food...
Alembic Pharma Shares Soar 3% as Panelav Unit Secures EIR
Alembic Pharmaceuticals Ltd stock price rose 3% in early trading on 30 April following the establishment inspection report (EIR) for its Panelav-based oncology formulation facility....